Auto-antibody Dosage From Blood Spots for Diagnosis of Type 1 Diabetes and Celiace Disease

Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Early diagnosis of type 1 diabetes and celiac disease is very useful, allows early therapy and prevents deaths from the onset of diabetic ketoacidosis. This is a pilot study on screening of autoantibodies of type 1 diabetes and celiac disease in tuscany patients. The study aims to evaluate the concordance between the screening results obtained using two different matrix (blood drop spots on card and serum) in the search for autoantibodies for celiac disease and for type 1 diabetes. Moreover, it will be evaluated the feasibility and acceptability of the screening on a sample of the population enrolled in the territory through the participation of pediatricians.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 2
Maximum Age: 13
Healthy Volunteers: f
View:

• Patients aged 2-13 years

• Patients with a confirmed diagnosis of type 1 diabetes or celiac disease (positive controls) and children who do not have type 1 diabetes or celiac disease or autoantibodies associated with these pathologies (controls)

• Obtained informed consent

Locations
Other Locations
Italy
Meyer Children's Hospital IRCCS
RECRUITING
Florence
Contact Information
Primary
Chiara Azzari
chiara.azzari@meyer.it
+3905556621
Time Frame
Start Date: 2024-11-04
Estimated Completion Date: 2026-03-30
Participants
Target number of participants: 1500
Treatments
Other: Test on blood sample (diagnosis of celiac and diabetes disease)
Other: test on dried blood spot (celiac and diabetes patients)
Sponsors
Leads: Meyer Children's Hospital IRCCS

This content was sourced from clinicaltrials.gov